Biotech

Queensland Bauxite Ltd (ASX:QBL) JV with Leading Israeli Medicinal Cannabis Company Pharmocann

🕔10/19/2018 9:51:24 AM

The Board of Queensland Bauxite Limited (ASX:QBL) is very pleased to announce a materially strategic transaction, that its soon to be wholly owned subsidiary Medcan Australia, has entered into a memorandum of understanding with top Israeli medicinal cannabis company Pharmocann.

Read Full Article

Oventus Medical Ltd (ASX:OVN) New Clinical Trial Data Demonstrates Sleep Treatment Platform Delivers Significantly Improved Treatment Outcomes for OSA Sufferers

🕔10/18/2018 10:24:42 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce that new clinical data from four separate studies on its Sleep Treatment Platform will be presented at Sleep DownUnder, the 30th annual meeting of sleep specialists, taking place in Brisbane between 17th -20th October.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Cover Note and Supplementary Prospectus

🕔10/18/2018 9:47:17 AM

This attached supplementary prospectus of Queensland Bauxite Ltd (ASX:QBL) has included some updated information on the original prospectus that was lodged with the ASIC on 27 September 2018.

Read Full Article

Regeneus Ltd (ASX:RGS) European Patent Office Issues Notice of Intention to Grant European Patent

🕔10/18/2018 9:11:57 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce it has received a Notice of Intention to Grant a European patent covering the use of Progenza by the European Patent Office.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Office of Drug Control Manufacture Licence Secured

🕔10/10/2018 8:35:54 AM

The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that its soon to be wholly owned subsidiary, Medcan Australia, has secured a Medical Cannabis Manufacture Licence under the ODC.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) 2018 Annual Report

🕔10/9/2018 8:31:26 AM

Anatara Lifesciences (ASX:ANR) is pleased to release its Annual Report, for the year ended 30th June 2018.

Read Full Article

Rhinomed Limited (ASX:RNO) Signs 12-Year Licensing Agreement with America's Largest Medical Cannabis Operator - Columbia Care LLC

🕔10/3/2018 8:30:39 AM

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC, the largest and most experienced provider of cannabis-based products and services in the United States (U.S.).

Read Full Article